Enzymatic assay for quantitative analysis of (d)-2-hydroxyglutarate

Acta Neuropathologica

Volumn 124, Issue 6, 2012, Pages 883-891

  Balss, Jörg ^a,b   Pusch, Stefan ^a,b   Beck, Ann Christin ^b   Herold Mende, Christel ^a   Krämer, Alwin ^a   Thiede, Christian ^c   Buckel, Wolfgang ^d,e   Langhans, Claus Dieter ^f   Okun, Jürgen G ^f   Von Deimling, Andreas ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^d PHILIPPS UNIVERSITY MARBURG   (Germany)

^e MAX PLANCK INSTITUTE FOR TERRESTRIAL MICROBIOLOGY   (Germany)

^f UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYGLUTARIC ACID; ISOCITRATE DEHYDROGENASE 1;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ENZYME ASSAY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; ISOCITRATE DEHYDROGENASE 1 GENE; LIMIT OF DETECTION; LIMIT OF QUANTITATION; NONHUMAN; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; QUANTITATIVE ANALYSIS; STEREOCHEMISTRY; VALIDATION PROCESS;

ALCOHOL OXIDOREDUCTASES; ENZYME ASSAYS; GLUTARATES; HUMANS; ISOCITRATE DEHYDROGENASE; LEUKEMIA, MYELOID, ACUTE; MUTATION; TUMOR MARKERS, BIOLOGICAL;

EID: 84878366798     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-012-1060-y     Document Type: Article

References (31)

1. Amary MF, Bacsi K, Maggiani F, Damato S, Halai D, Berisha F, Pollock R, O'Donnell P, Grigoriadis A, Diss T, Eskandarpour M, Presneau N, Hogendoorn PC, Futreal A, Tirabosco R, Flanagan AM (2011) IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. J Pathol 224:334-343
2. Balss J, Meyer J, Mueller W, Korshunov A, Hartmann C, von Deimling A (2008) Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol 116:597-602
3. Borger D, Tanabe K, Fan K, Lopez H, Fantin V, Straley K, Schenkein D, Hezel A, Ancukiewicz M, Liebman H, Kwak E, Clark J, Ryan D, Deshpande V, Dias-Santagata D, Ellisen L, Zhu A, Iafrate A (2012) Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping. Oncologist 17:72-79
4. Buckel W (1980) The reversible dehydration of (R)-2-hydroxyglutarate to (E)-glutaconate. Eur J Biochem 106:439-447
5. Bueno C, Villegas ML, Bertolotti SG, Previtali CM, Neumann MG, Encinas MV (2002) The excited-state interaction of resazurin and resorufin with amines in aqueous solutions. Photophysics and photochemical reactions. Photochem Photobiol 76:385-390
6. Cairns RA, Iqbal J, Lemonnier F, Kucuk C, Ld Leval, Jais J-P, Parrens M, Martin A, Xerri L, Brousset P, Chan LC, Chan W-C, Gaulard P, Mak TW (2012) IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma. Blood 119:1901-1903
7. Candeias LP, MacFarlane DPS, McWhinnie SLW, Maidwell NL, Roeschlaub CA, Sammes PG, Whittlesey R (1998) The catalysed NADH reduction of resazurin to resorufin. J Chem Soc Perkin Trans 2:2333-2334
8. Capper D, Zentgraf H, Balss J, Hartmann C, von Deimling A (2009) Monoclonal antibody specific for IDH1 R132H mutation. Acta Neuropathol 118:599-601
9. Chalmers RA, Lawson AM, Borud O (1977) Gas chromatographic and mass spectrometric studies on urinary organic acids in a patient with congenital lactic acidosis due to pyruvate decarboxylase deficiency. Clin Chim Acta 77:117-124
10. Chalmers RA, Lawson AM, Watts RW, Tavill AS, Kamerling JP, Hey E, Ogilvie D (1980) d-2-Hydroxyglutaric aciduria: case report and biochemical studies. J Inherit Metab Dis 3:11-15
11. Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC, Marks KM, Prins RM, Ward PS, Yen KE, Liau LM, Rabinowitz JD, Cantley LC, Thompson CB, Vander Heiden MG, Su SM (2009) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462:739-744
12. Goodman SI, McCabe ERB, Fennessey PV, Mace JW (1980) Multiple acyl-CoA dehydrogenase deficiency (glutaric aciduria type II) with transient hypersarcosinemia and sarcosinuria; possible inherited deficiency of an electron transfer flavoprotein. Pediatr Res 14:12-17
13. Hartmann C, Meyer J, Balss J, Capper D, Mueller W, Christians A, Felsberg J, Wolter M, Mawrin C, Wick W, Weller M, Herold-Mende C, Unterberg A, Jeuken J, Wesseling P, Reifenberger G, von Deimling A (2009) Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1010 diffuse gliomas. Acta Neuropathol 118:469-474
14. Hoffmann GF, Jakobs C, Holmes B, Mitchell L, Becker G, Hartung HP, Nyhan WL (1995) Organic acids in cerebrospinal fluid and plasma of patients with l-2-hydroxyglutaric aciduria. J Inherit Metab Dis 18:189-193
15. Kranendijk M, Struys EA, Schaftingen Ev, Gibson KM, Kanhai WA, Knaap MSvd, Amiel J, Buist NR, Das AM, Klerk JBd, Feigenbaum AS, Grange DK, Hofstede FC, Holme E, Kirk EP, Korman SH, Morava E, Morris A, Smeitink J, Sukhai RN, Vallance H, Jakobs C, Salomons GS (2010) IDH2 Mutations in patients with d-2-hydroxyglutaric aciduria. Science 330:336-336
16. Kuhara T, Shinka T, Inoue Y, Matsumoto M, Yoshino M, Sakaguchi Y, Matsumoto I (1983) Studies of urinary organic acid profiles of a patient with dihydrolipoyl dehydrogenase deficiency. Clin Chim Acta Int J Clin Chem 133:133-140
17. Leonardi R, Subramanian C, Jackowski S, Rock CO (2012) Cancer-associated isocitrate dehydrogenase mutations inactivate NADPH-dependent reductive carboxylation. J Biol Chem 287:14615-14620
18. Long GL, Winefordner JD (1983) Limit of detection. A closer look at the IUPAC definition. Anal Chem 55:712-724
19. Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan MD, Chen K, Koboldt DC, Fulton RS, Delehaunty KD, McGrath SD, Fulton LA, Locke DP, Magrini VJ, Abbott RM, Vickery TL, Reed JS, Robinson JS, Wylie T, Smith SM, Carmichael L, Eldred JM, Harris CC, Walker J, Peck JB, Du F, Dukes AF, Sanderson GE, Brummett AM, Clark E, McMichael JF, Meyer RJ, Schindler JK, Pohl CS, Wallis JW, Shi X, Lin L, Schmidt H, Tang Y, Haipek C, Wiechert ME, Ivy JV, Kalicki J, Elliott G, Ries RE, Payton JE, Westervelt P, Tomasson MH, Watson MA, Baty J, Heath S, Shannon WD, Nagarajan R, Link DC, Walter MJ, Graubert TA, Dipersio JF, Wilson RK, Ley TJ (2009) Recurring mutations found by sequencing an acute myeloid leukemia genome. New Engl J Med 361:1058-1066
20. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, Olivi A, McLendon R, Rasheed BA, Keir S, Nikolskaya T, Nikolsky Y, Busam DA, Tekleab H, Diaz LA Jr, Hartigan J, Smith DR, Strausberg RL, Marie SK, Shinjo SM, Yan H, Riggins GJ, Bigner DD, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807-1812
21. Paschka P, Schlenk RF, Gaidzik VI, Habdank M, Kronke J, Bullinger L, Spath D, Kayser S, Zucknick M, Gotze K, Horst HA, Germing U, Dohner H, Dohner K (2010) IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication. J Clin Oncol 28:3636-3643
22. Pollyea D, Kohrt H, Zhang B, Zehnder J, Schenkein D, Fantin V, Straley K, Vasanthakumar A, Abdel-Wahab O, Levine R, Godley L, Medeiros B (2013) 2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels. Leuk Lymphoma (Epub ahead of print)
23. Sahm F, Capper D, Pusch S, Balss J, Koch A, Langhans C, Okun J, von Deimling A (2012) Detection of 2-hydroxyglutarate in formalin-fixed paraffin-embedded glioma specimens by gas-chromatography/mass-spectrometry. Brain Pathol 22:26-31
24. Sellner L, Capper D, Meyer J, Langhans C, Hartog C, Pfeifer H, Ho A, Okun J, Krämer A, von Deimling A (2010) Increased levels of 2-hydroxyglutarate in AML patients with IDH1-R132H and IDH2-R140Q mutations. Eur J Haematol 85:457-459
25. Soundar S, Danek BL, Colman RF (2000) Identification by mutagenesis of arginines in the substrate binding site of the porcine NADP-dependent isocitrate dehydrogenase. J Biol Chem 275:5606-5612
26. Sponholz W-R, Wünsch B, Dittrich HH (1981) Enzymatische Bestimmung von (R)-2-Hydroxyglutarsäure in Mosten, Weinen und anderen Gärungsgetränken. Zeitschrift für Lebensmitteluntersuchung und -Forschung A 172:264-268
27. Struys EA, Salomons GS, Achouri Y, Van Schaftingen E, Grosso S, Craigen WJ, Verhoeven NM, Jakobs C (2005) Mutations in the d-2-hydroxyglutarate dehydrogenase gene cause d-2-hydroxyglutaric aciduria. Am J Hum Genetics 76:358-360
28. Van Biervliet JPGM, Bruinvis L, van der Heiden C, Ketting D, Wadman SK, Willemse JL, LaH Monnens (1977) Report of a patient with severe, chronic lactic acidaemia and pyruvate carboxylase deficiency. Dev Med Child Neurol 19:392-401
29. Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, Friedman H, Friedman A, Reardon D, Herndon J, Kinzler KW, Velculescu VE, Vogelstein B, Bigner DD (2009) IDH1 and IDH2 mutations in gliomas. New Engl J Med 360:765-773
30. Yu X, Bresser J, Schall I, Djurdjevic I, Buckel W, Wang X, Engel P (2012) Development of a satisfactory and general continuous assay for aminotransferases by coupling with (R)-2-hydroxyglutarate dehydrogenase. Anal Biochem 431:127-131
31. Zhang J-H, Chung TDY, Oldenburg KR (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4:67-73